The revisions are for The Joint Commission’s ORYX initiative, which measures hospital performance data as part of the accreditation process.
These new revisions were inspired by the CDC’s National Healthcare Safety Network, which serves as a “data source to identify patient safety and quality performance by Joint Commission-accredited hospitals that already participate in NHSN as required by [CMS] programs,” the release states.
Acute and critical access hospitals joining the effort will allow The Joint Commission to strengthen its own data resources and see areas where quality improvements can be made.
These hospitals will required to share de-identified data across five measurement areas beginning Jan. 1, 2024:
- Catheter-associated urinary tract infection outcomes
- Facilitywide inpatient hospital-onset clostridium difficile infection outcomes
- Central line-associated bloodstream infection outcomes
- Colon and abdominal hysterectomy surgical site infection outcomes
- Facilitywide inpatient hospital-onset methicillin-resistant staphylococcus aureus bacteremia outcomes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
